LENZ Therapeutics, Inc. (LENZ) › Cash & EquivalentsLENZ Therapeutics, Inc. (LENZ) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2020-12-31: $19.78M2021-12-31: $376.98M2022-12-31: $47.73M2023-12-31: $35.14M2024-12-31: $20.16M2025-12-31: $25.18M$25.18M2020-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$25.18M+24.9%2026-03-24Balance as of period end2024-12-31$20.16M-42.6%2026-03-24Balance as of period end2023-12-31$35.14M-26.4%2025-03-19Balance as of period end2022-12-31$47.73M-87.3%2024-02-27Balance as of period end2021-12-31$376.98M+1805.7%2023-03-20Balance as of period end2020-12-31$19.78M—2022-03-21Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)